Apoptotic abscess imaging with 99mTc-HYNIC-rh-Annexin-V

David L Penn1, Christopher Kim, Kaijun Zhang

  • 1Department of Radiology, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Insights

This study developed a new imaging agent, technetium-99m-labeled Annexin-V (99mTc-AnxV), to detect abscesses. The agent successfully targeted apoptotic neutrophils in abscesses, showing promise for distinguishing infectious from inflammatory causes.

Area of Science:

  • Nuclear Medicine
  • Immunology
  • Pathology

Background:

  • Abscess formation involves neutrophil signaling and apoptosis, leading to phosphatidylserine externalization.
  • Annexin-V (AnxV) binds to externalized phosphatidylserine on apoptotic cells.

Purpose of the Study:

  • To develop and evaluate 99mTc-labeled AnxV (99mTc-AnxV) as an imaging agent for abscesses.
  • To assess the agent's ability to target apoptotic polymorphonuclear leukocytes (PMNs) in abscesses.

Main Methods:

  • AnxV was conjugated with HYNIC and labeled with 99mTc.
  • Apoptosis was induced in human PMNs, and binding of 99mTc-HYNIC-AnxV was quantified.
  • Abscesses were induced in mice, and biodistribution of 99mTc-HYNIC-AnxV was studied post-injection.

Main Results:

  • 99mTc-HYNIC-AnxV demonstrated high radiochemical purity.
  • The agent showed significantly higher binding to apoptotic PMNs compared to control cells.
  • In vivo imaging revealed accumulation of 99mTc-HYNIC-AnxV in bacterial abscesses, with higher uptake than turpentine-induced abscesses.

Conclusions:

  • 99mTc-HYNIC-AnxV effectively targets apoptotic PMNs.
  • This agent shows potential as a minimally invasive tool for imaging abscesses.
  • It may help differentiate between infectious and inflammatory abscesses.

Related Concept Videos